IN this paper we wish to discuss a subacute form of encephalopathy which has been rediscovered in recent years, and which though possibly rare, has many features of interest. both clinical and pathological. It has no accepted designation, the nature of the disease not being established and it has therefore been described in the literature under different titles. Spielmeyer (1922) illustrated the condition and referred to it as a peculiar disease process of late adult life. He made use of it in order to exemplify status spongiosus, by which he meant a softening of the nervous tissue (as distinct from the usual ischmmic softening) resulting from a failure of the glia to fill the cavities in the tissue.
A Form of Subacute Encephalopathy of Uncertain AEtiology By S. NEVIN, M.D., F.R.C.P., and W. H. MCMENEMEY, M.D., F.R.C.P.
London IN this paper we wish to discuss a subacute form of encephalopathy which has been rediscovered in recent years, and which though possibly rare, has many features of interest. both clinical and pathological. It has no accepted designation, the nature of the disease not being established and it has therefore been described in the literature under different titles. Spielmeyer (1922) illustrated the condition and referred to it as a peculiar disease process of late adult life. He made use of it in order to exemplify status spongiosus, by which he meant a softening of the nervous tissue (as distinct from the usual ischmmic softening) resulting from a failure of the glia to fill the cavities in the tissue.
In 1930 Hallervorden, under the heading of "peculiar and non-classifiable conditions", gave a short but good account of the case from which Spielmeyer had taken his illustration. As well as the status spongiosus and glial proliferation pictured by Spielmeyer, Hallervorden described a loss of nerve cells with the residual nerve cells exhibiting severe changes (in the sense of Nissl) and cell shrinkage, the former affected mainly the larger, and the latter the smaller nerve cells. The whole cerebral cortex was involved, but especially the posterior parts: Hallervorden, in fact, described the occipital grey matter as being so filled with glial cells that everything else seemed embedded in the protoplasmic mass of their cell bodies. The patient was a 60-year-old woman and the duration of her illness was three months. It was characterised by progressive mental deterioration and focal symptoms referable to the left temporo-occipital region. The onset was possibly gradual; she became silly, perverse and forgetful and was anxious and unable to express herself properly or find her own room. In the clinic she tottered as she walked, tended to hold her arms outstretched or to make flinging movements with them. A right hemianopia, alexia, nominal aphasia, spatial disorientation and apraxia could all be demonstrated before severe mental deterioration set in with perseveration, senseless speech and much excitement. She died from erysipelas. Hallervorden correlated the focal symptoms with severe cortical changes in the left temporal lobe.
The first example of this condition, however, was probably described by Fischer in 1911 in a paper on the pathology of status spongiosus. He found the typical cortical changes of this type of encephalopathy throughout both cerebral hemispheres, but more on the left side and especially in the left temporal lobe of a man of 70. The clinical details were scanty. He had had a left-sided hemiplegia ten years previously from which he had made a good recovery. Four months before his death he is described as having had another stroke resulting in aphasia and clinical signs of severe temporal lobe disease. An old softening was found in the right thalamus but the temporal lobe disturbances were due to a diffuse cortical degeneration closely paralleling that demonstrated by Hallervorden for his case. The typical mental changes are not mentioned in the report, but so little is said on the clinical side that it would probably not be right to assume that they were absent.
The first detailed clinical and pathological account was that of Heidenhain in 1928 and it concerned 3 patients in whose brains were found cortical lesions identical with those already described, affecting in the first 2 cases the parieto-occipital regions principally, but in the third the whole cortex. In the first case status spongiosus was not present. Heidenhain emphasised the occurrence of cell shrinkage and in one case he described these cells as being present without number. He noted involvement of the striatum in Cases 2 and 3 with loss of small nerve cells, and swelling and loss of processes in those remaining. Cavitation in the corpus striatum and in the thalamus, with some loss of Purkinje cells was noted in Case 3. A prominent focal symptom in Heidenhain's cases was visual impairment progressing to cortical blindness. It was, however, eight weeks before the first and seven weeks before the second patient gave up reading. In both these patients the organic confusional state developed after this and progressed rapidly as if the pathological process was extending and building up over wider cortical fields. Incoordination and athetoid movements of the hands were noted in the later stages, possibly due to parietal lobe or striatal damage. It is not possible to feel certain of the cause of the board-like rigidity of the limbs which Heidenhain described but it is probably due to a release phenomenon following cortical and striatal damage rather than to discharging cortical lesions. In the third case the physical symptoms affecting predominantly the left arm and lasting five to six years is a highly significant feature. The cord was not examined, but it seems probable that the pathology accounting for these symptoms was similar to that which advanced so rapidly in the final four months and the severe status spongiosus in the corpus striatum and pallidal lesions may be related to this aspect of the clinical story. This is an isolated finding in about 17 cases so far recorded in whole or in part, but if it appears in other cases it must materially affect discussion as to the nature of the disease.
Our attention was first attracted to this condition in 1951 by the abnormal EEG findings in one patient, findings which, if encephalitis could be excluded, indicated a severe cerebral disorder of an unusual kind.
The striking features were the sharp wave complexes probably independent of any associated slow wave which built up synchronously in all areas of the cortex. Patterns approaching this in form have been found in all 5 cases of this disease which we have observed.
In the early stages of the illness, however, sharp wave complexes may not be present, the EEG showing only generalised slow activity. In Foley and Denny-Brown's cases (1955) , to be referred to later, the sharp wave complexes did not appear so that the EEG findings, while very helpful, are not necessarily diagnostic. Apart from the EEG findings our cases show that the sensory and motor cortex may be affected first, giving rise to quadriplegia instead of cortical blindness as the initial symptom. One case corresponded closely to those of Heidenhain without the intense board-like rigidity, while in another initial symptoms pointed to early involvement of the cerebellum in the disease. It is right to infer that in these instances the pathological process begins locally, either in the cortex or cerebellum and later extends in the cortex giving rise to a severe organic confusional state and later gross mental deterioration. In 2 patients, however, mental symptoms predominated and focal symptoms, while present later, were not conspicuous. Perhaps in these cases wide areas of the frontal or temporal cortex are involved simultaneously giving rise as the disease advances to severe psychic disintegration and death. All 5 cases showed myoclonic epilepsy in the later stages.
On the pathological side the cortical changes were widespread and identical with those described by Heidenhain except that the status spongiosus was more extreme in one case involving also the molecular layer. Furthermore the thalamus, corpus striatum and pallidum were severely involved in 4 of the cases. In one the cerebellum showed a status spongiosuslike lesion at the junction of the molecular and granular layer and many Purkinje cells were lost. Severe degeneration was also found in the olives in one case. In 4 out of 5 of these cases, however, there were multiple softenings in the brain lesions which could not be labelled terminal or agonal and the possible significance of these will be referred to later.
In a paper entitled "A case of senile dementia (Heidenhain's syndrome) associated with cortical blindness", Meyer et al. described in 1954 an instance of the disease in a man of 38 in whom mental changes appeared initially, became extreme after four months, and ended in death at six months. Here, the cortical changes were severe with gross disintegration of the occipital cortex with neuroglial reaction and myelin loss. There was also some demyelination in the occipital white matter, but whether primary or secondary to the cortical damage the authors did not discuss. In 1955, Foley and Denny-Brown gave a preliminary report of two cases confirmed pathologically which add further to the clinical and pathological features of this disease. Ataxia of the trunk and limbs were initial symptoms and in the later weeks when an organic confusional state had developed, rhythmical myoclonus of the upper limbs occurred periodically associated with chewing movements of the jaw, lips and tongue. The first patient was in deep stupor, with arms adducted and semiflexed and legs extended, for seven months before death. In this case the cortical and basal ganglia atrophy was severe; the thickness of the cortex being greatly reduced and in places with hardly a viable nerve cell left. This is to be correlated with the patient having survived seven months after the disease had reached maximum, so to speak. There was also, in the patient, marked naked-eye atrophy of the cerebellum and gross degeneration of the granule layer and of the Purkinje cells with status spongiosus formation in this region. In the white matter of the brain, brain-stem, and in the pyramidal tracts there was some degeneration, considered by the authors to be secondary to the cell loss.
Section of Neurology
Two further instances of the disease studied clinically by Dr. Behrman at the Brook Hospital are at present being investigated. They showed variations of the clinical picture already described, but possibly no new features. The same may be said of two examples (Cases 1 and 3) of this disease described in 1957 by Pallis and Spillane in a paper entitled "A subacute progressive encephalopathy with mutism, hypokinesia, rigidity and myoclonus."
It cannot be disputed that we have, in the cases here referred to, a subacute progressive disease of the nervous system with consistent clinical and pathological features. The age of patients affected range from 38 to 70 years and the disease has progressed to a fatal issue in from two to six months with two striking exceptions to which reference has already been made.
The disease seems to commence sharply, if mildly, and is signalled by symptoms pointing to focal damage in any part of the cerebral hemispheres, the cerebellum or basal ganglia or by a commencing dementia, perhaps associated sometimes with such general symptoms as headache, giddiness, lassitude, insomnia, or pains in the limbs. There is some variation in the progression of the disease, symptoms advancing quickly over two to four weeks or changing little for seven to eight weeks as was the case with the visual symptoms in three patients. Also focal symptoms may advance for ten to twelve weeks before an organic confusional state develops or the latter may appear alone and advance greatly so as to make the clinical detection of late developing focal symptoms impossible.
Muscular rigidity of extreme degree and exaggerated by movement or other stimuli can occur and also a wide range of involuntary movements, tremor, athetosis or myoclonus of marked degree as well as epilepsy and myoclonic epilepsy. It seems that the myoclonus described by Foley and Denny-Brown is a unique symptom which they attribute to the combined cortical and cerebellar lesion. Also a grasp reflex is not infrequently present. The mental deterioration becomes extreme, the patient speechless, stuporous, immobile, incontinent and flaccid, or more often rigid with the arms flexed and adducted and the legs either extended or flexed. This posture has been referred to as the decorticate posture, but no postural reflexes have been described and it is doubtful if the term has any precise meaning in the human subject, as one does not know how much the rigid state is due to cortical, basal ganglia or even cerebellar damage. All investigations are more or less negative, but a slight increase of protein in the C.S.F. has been recorded. Air and arteriographic studies have not shown any striking or consistent changes.
The specific pathological changes in the cortex, basal ganglia and cerebellum, with little evidence so far of significant involvement of the brain stem or spinal cord-apart from the olives, explains the clinical picture in all its variations. The pathological changes may vary greatly in severity from case to case and from region to region.
We now come to a discussion of the nature of this disease and the first question which arises is whether it is or is not related to, or an integral part of, corticostriatospinal degeneration or Creutzfeldt-Jacob disease. Meyer et al. appear to consider it as a variety of the Creutzfeldt-Jacob group, for which the name Heidenhain's syndrome should be used. Bornstein and Jervis (1955) in America and Jacob et al. in Germany (1950) include Heidenhain's cases without question in the same Creutzfeldt-Jacob group, stating that the pathological changes are identical. Foley and Denny-Brown, in presenting their cases to the American Association of Neuropathologists, say that they have studied three patients with " Jacob's pseudosclerosis" whose clinical pictures were so distinctive and yet so different from the usual clinical and pathological description of this disease that they wished to bring it to general attention. The clinical differences between the two diseases are, therefore, admitted and it is mainly in the pathological field that doubt arises.
It might be best, therefore, first to make clear what Heidenhain thought about this problem. Although Meyer et al. state that Heidenhain considered his cases as closely related to Jacob's pseudosclerosis this is not how we read his paper. In fact he lists six anatomical features which distinguish them from it, viz.:
(1) The disease process exclusively affects the grey matter, is diffuse and foci are not evident.
(2) Severe affection of parts of the cortex other than the temporo-central areas, especially the occipital areas.
(3) Cell shrinkage is more marked.
(4) The glial reaction is different, gliarasen rosettes and neuronophagy do not occur.
(5) Fatty degeneration of neurones is not so marked.
(6) Myelin fibres are better retained.
Also he states categorically that it is not possible on account of these differences without further evidence to place his cases in the same category as Jacob's pseudosclerosis. No further evidence has appeared and we know of no reasoned answer to Heidenhain's argument. In fact the further experience of the two types of case supports Heidenhain's viewpoint. The extreme status spongiosus which can occur in the Fischer-Heidenhain type of case indicating a cytolysis of neurones rather than an atrophy and the absence of lower motor neurone involvement in the brain-stem and spinal cord are other striking differences between the two diseases.
Corticostriatospinal degeneration is a well-recognised degenerative syndrome easy to diagnose when the complete picture is present with a pathology of the same order as that 53$ occurring in motor neurone disease but extending over wider fields in the nervous system. Even in its most acute form the pathology does not resemble that present in the encephalopathy described here. Jacob and Spielmeyer apparently knew both diseases and there is no evidence that they linked them in any way.
If then the form of encephalopathy under discussion, and which might usefully be referred to as subacute encephalopathy with spongiose atrophy of the cerebral grey matter, is different from Jacob's corticostriatospinal degeneration, of what nature is it?
Foley and Denny-Brown have postulated a primary degeneration of the neuroglia, but this viewpoint may be difficult to substantiate. Foley and Denny-Brown actually describe the neuroglial processes as cut off by the disease which could mean a destructive process involving an area of cortical groundwork carrying with it also the nervous parenchyma. If this is so then a pathology involving vascular dysfunction must first be excluded. In a paper from Maida Vale (Jones and Nevin, 1954) it was postulated that some form of vascular insufficiency at the arteriole or capillary level resulting either in stasis with fluid exudation or in impaired absorption with consequent nutritional failure could be the cause of the lesions. This was done for the following reasons, it being recognized that structural changes in the vessels were not adequate to account for any failure of the blood flow.
(1) It is certain that status spongiosus, although a non-specific change, can occur'on a vascular basis, and it is difficult in the absence of any other clinical or pathological abnormality elsewhere in the body to think of any other explanation for the extreme softening of the :cortex that can occur in this disease.
(2) Heidenhain in one of his cases actually described the myelinated fibres as ballooned apart by fluid, but he does not say where the fluid came from or why it appeared.
(3) The glial' reaction in the disease, while not in any way specific, is such as could' occur in a vascular pathblogy. It is not different from that which can occur in the neighbourhood of cortical softenings and is, at times, typically gemistocytic in type in the molecular layer. Also a pronounced microglial reaction or gitter cell formation can occur in the severest cases.
(4) Of the 17 cases so far known softenings have been found in no fewer than 8, good circumstantial evidence of vascular dysfunction.
It may also be mentioned that Ajuriaguerra and his co-workers (1,953) in France have in fact spoken of the cortical lesion in Heidenhain's cases as possibly vascular because of the presence of status spongiosus.
One of our patients was given Priscol with such a rapid increase in the myoclonic jerks that he had to be given intravenous barbiturates, a treatment not necessary on any other occasion. One other patient had slight evidence of a shift in the arteriogram in the anterior cerebral artery possibly due to swelling of one hemisphere. Also we have some evidence, both clinically and pathologically, of this type of cortical lesion occurring in the right hemisphere of an elderly diabetic with extensive left carotid thrombosis, and EEG evidence of it occurring also temporarily in one hemisphere after removal of a meningioma. It would not be right to assume, therefore, that the condition is always fatal and it is also possible that if a vascular basis for the disease is established an effective treatment may be'found.
In conclusion it seems to us also that the clinical symptoms in their great variability (pointing to disturbances in all areas of the cerebral grey matter) in their abrupt progression and occasional sudden onset, are not inconsistent with some form of vascular dysfunction.
